MoneyWorks4Me

Genomic Valley Biotech submits intimation of approval of extension of time for holding AGM

31 Aug 2026 Evaluate
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, Genomic Valley Biotech has informed that at the request of the Company, Registrar of Companies, Haryana vide its letter dated 30th August, 2026, has accorded approval for extension of time for holding Annual General Meeting (AGM) of the Company for the financial year ended 31st March, 2026 by 3 months i.e. up to 31st December, 2026, which was earlier due to be held on or before 30th September, 2026. Date of Annual General Meeting will be intimated in due course of time as and when it is decided by the Board of Directors of the Company.

The above information is a part of company’s filings submitted to BSE.

Genomic Valley Bio. Share Price

29.88 0.00 (0.00%)
04-Sep-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys (India) 1659.50
Mangalam Global Ent. 14.25
Kaveri Seed 744.10
Regaal Resources 88.54
Simran Farms 186.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: